Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Qian Ye, Xiaowen Han & Zhengsheng Wu. (2020) Bioinformatics analysis to screen key prognostic genes in the breast cancer tumor microenvironment. Bioengineered 11:1, pages 1280-1300.
Read now
Read now
Luigi Cari, Giuseppe Nocentini, Graziella Migliorati & Carlo Riccardi. (2018) Potential effect of tumor-specific Treg-targeted antibodies in the treatment of human cancers: A bioinformatics analysis. OncoImmunology 7:2.
Read now
Read now
Theresa L Whiteside. (2015) The role of regulatory T cells in cancer immunology. ImmunoTargets and Therapy 4, pages 159-171.
Read now
Read now
Theresa L Whiteside. (2015) The potential of tumor-derived exosomes for noninvasive cancer monitoring. Expert Review of Molecular Diagnostics 15:10, pages 1293-1310.
Read now
Read now
Alison Sehgal, Theresa L Whiteside & Michael Boyiadzis. (2015) Programmed death-1 checkpoint blockade in acute myeloid leukemia. Expert Opinion on Biological Therapy 15:8, pages 1191-1203.
Read now
Read now
Articles from other publishers (62)
Sulieman Ibraheem Shelash Al-Hawary, Khadisha Kashikova, Elena M. Ioffe, Almaral Izbasarova, Ahmed Hjazi, Nahla A. Tayyib, Ali Alsalamy, Beneen M. Hussien, Mohamood Hameed & Mays Jassim abdalkareem. (2023) Pathological role of LncRNAs in immune-related disease via regulation of T regulatory cells. Pathology - Research and Practice 249, pages 154709.
Crossref
Crossref
Jana Friedhoff, Felix Schneider, Christina Jurcic, Volker Endris, Martina Kirchner, Angela Sun, Iulia Bolnavu, Laura Pohl, Miriam Teroerde, Maximilian Kippenberger, Constantin Schwab, Adam Kaczorowski, Stefanie Zschäbitz, Dirk Jäger, Markus Hohenfellner, Albrecht Stenzinger, Anette Duensing & Stefan Duensing. (2022) BAP1 and PTEN mutations shape the immunological landscape of clear cell renal cell carcinoma and reveal the intertumoral heterogeneity of T cell suppression: a proof-of-concept study. Cancer Immunology, Immunotherapy 72:6, pages 1603-1618.
Crossref
Crossref
Soumaya Rafii, Sarah Kandoussi, Amina Ghouzlani, Oumayma Naji, Konala Priyanka Reddy, Rizwan Ullah Sadiqi & Abdallah Badou. (2023) Deciphering immune microenvironment and cell evasion mechanisms in human gliomas. Frontiers in Oncology 13.
Crossref
Crossref
Francesca Parisi, Francesca Millanta, Marika Nicastro, Iacopo Vannozzi & Alessandro Poli. (2023) Confirmation of the Prognostic Value of Foxp3+ Cells in Canine Mammary Tumors. Animals 13:3, pages 505.
Crossref
Crossref
Minjeong Kim, Na Kyeong Lee, Chi-Pin James Wang, Jaesung Lim, Min Ji Byun, Tae-Hyung Kim, Wooram Park, Dae-Hwan Park, Se-Na Kim & Chun Gwon Park. (2023) Reprogramming the tumor microenvironment with biotechnology. Biomaterials Research 27:1.
Crossref
Crossref
Sotirios P. Fortis, Michael Sofopoulos, Maria Goulielmaki, Niki Arnogiannaki, Alexandros Ardavanis, Sonia A. Perez, Angelos D. Gritzapis & Constantin N. Baxevanis. (2022) Association between Intratumoral CD8+ T Cells with FoxP3+ and CD163+ Cells: A Potential Immune Intrinsic Negative Feedback Mechanism for Acquired Immune Resistance. Cancers 14:24, pages 6208.
Crossref
Crossref
Yi He, Haiting Zhou, Xiaojian Huang, Yunkun Qu, Yingguang Wang, Wenbin Pei, Rui Zhang, Sheng Chen & Hongbo You. (2022) Infiltration of LPAR5+ macrophages in osteosarcoma tumor microenvironment predicts better outcomes. Frontiers in Immunology 13.
Crossref
Crossref
Mali Coray, Veronika Göldi, Lukas Schmid, Laura Benecke, Fabrício Figueiró & Laurent Muller. (2022) Differential Immunomodulatory Effects of Head and Neck Cancer-Derived Exosomes on B Cells in the Presence of ATP. International Journal of Molecular Sciences 23:22, pages 14446.
Crossref
Crossref
Shangbo Lei, Jiamin Jin, Xiangfeng Zhao, Lihua Zhou, Guangying Qi & Jinfeng Yang. (2022) The role of IL-33/ST2 signaling in the tumor microenvironment and Treg immunotherapy. Experimental Biology and Medicine 247:20, pages 1810-1818.
Crossref
Crossref
Elham Gholipour, Houman Kahroba, Nasim Soltani, Parisa Samadi, Parisa Sarvarian, Sajjad Vakili‐Samiani, Abbas Ali Hosein Pour Feizi, Mohammad Sadegh Soltani‐Zangbar, Adel Baghersalimi, Bahram Darbandi, Aliakbar Movassaghpour, Mehdi Talebi, Roza Motavalli, Amir Mehdizadeh, Abdolhassan Kazemi & Mehdi Yousefi. (2022) Paediatric pre‐B acute lymphoblastic leukaemia‐derived exosomes regulate immune function in human T cells. Journal of Cellular and Molecular Medicine 26:16, pages 4566-4576.
Crossref
Crossref
Ram Hari Pokhrel, Suman Acharya, Jae-Hee Ahn, Ye Gu, Mahesh Pandit, Jong-Oh Kim, Yun-Yong Park, Ben Kang, Hyun-Jeong Ko & Jae-Hoon Chang. (2021) AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway. Molecular Cancer 20:1.
Crossref
Crossref
V. E. Mukhin, Yu. S. Konstantinova, R. R. Gimadiev & N. V. Mazurchik. (2021) Horizons of development of immunotherapy for malignant liver tumors. Experimental and Clinical Gastroenterology:7, pages 81-89.
Crossref
Crossref
Arezki Chekaoui & Hildegund C.J. Ertl. (2021) PPARα Agonist Fenofibrate Enhances Cancer Vaccine Efficacy. Cancer Research 81:17, pages 4431-4440.
Crossref
Crossref
Alexa C. Glencer, Jasmine M. Wong, Nola M. Hylton, Gregor Krings, Emma McCune, Harriet T. Rothschild, Tristan A. Loveday, Michael D. Alvarado, Laura J. Esserman & Michael J. Campbell. (2021) Modulation of the immune microenvironment of high-risk ductal carcinoma in situ by intralesional pembrolizumab injection. npj Breast Cancer 7:1.
Crossref
Crossref
Gary D Luker, Jinming Yang, Ann Richmond, Stefania Scala, Claudio Festuccia, Margret Schottelius, Hans-Jürgen Wester & Johann Zimmermann. (2021) At the Bench: Pre-clinical evidence for multiple functions of CXCR4 in cancer. Journal of Leukocyte Biology 109:5, pages 969-989.
Crossref
Crossref
Weinan Wang, Rui Zou, Ye Qiu, Jishuang Liu, Yu Xin, Tianzhu He & Zhidong Qiu. (2021) Interaction Networks Converging on Immunosuppressive Roles of Granzyme B: Special Niches Within the Tumor Microenvironment. Frontiers in Immunology 12.
Crossref
Crossref
Veronica Olivo Pimentel, Damiënne Marcus, Alexander MA van der Wiel, Natasja G Lieuwes, Rianne Biemans, Relinde IY Lieverse, Dario Neri, Jan Theys, Ala Yaromina, Ludwig J Dubois & Philippe Lambin. (2021) Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19–IL2 cures poorly immunogenic tumors when combined with radiotherapy. Journal for ImmunoTherapy of Cancer 9:3, pages e001764.
Crossref
Crossref
Fatemeh Bayati, Mahsa Mohammadi, Maryam Valadi, Saeid Jamshidi, Arron Munggela Foma & Ehsan Sharif-Paghaleh. (2021) The Therapeutic Potential of Regulatory T Cells: Challenges and Opportunities. Frontiers in Immunology 11.
Crossref
Crossref
Koushan Sineh Sepehr, Alireza Razavi, Zuhair Mohammad Hassan, Abdolreza Fazel, Meghdad Abdollahpour-Alitappeh, Majid Mossahebi-Mohammadi, Mir Saeed Yekaninejad, Behrouz Farhadihosseinabadi & Seyed Mahmoud Hashemi. (2020) Comparative immunomodulatory properties of mesenchymal stem cells derived from human breast tumor and normal breast adipose tissue. Cancer Immunology, Immunotherapy 69:9, pages 1841-1854.
Crossref
Crossref
Jan C. Schroeder, Lisa Puntigam, Linda Hofmann, Sandra S. Jeske, Inga J. Beccard, Johannes Doescher, Simon Laban, Thomas K. Hoffmann, Cornelia Brunner, Marie-Nicole Theodoraki & Patrick J. Schuler. (2020) Circulating Exosomes Inhibit B Cell Proliferation and Activity. Cancers 12:8, pages 2110.
Crossref
Crossref
James D. FisherStephen C. Balmert, Wensheng Zhang, Riccardo Schweizer, Jonas T. SchniderChiaki KomatsuLiwei DongVasil E. ErbasJignesh V. UnadkatAli Mübin AralAbhinav P. AcharyaYalcin KulahciHeth R. Turnquist, Angus W. ThomsonMario G. SolariVijay S. GorantlaSteven R. Little. (2019) Treg-inducing microparticles promote donor-specific tolerance in experimental vascularized composite allotransplantation. Proceedings of the National Academy of Sciences 116:51, pages 25784-25789.
Crossref
Crossref
Guanglin Cui, Zhenfeng Li, Jingli Ren & Aping Yuan. (2019) IL-33 in the tumor microenvironment is associated with the accumulation of FoxP3-positive regulatory T cells in human esophageal carcinomas. Virchows Archiv 475:5, pages 579-586.
Crossref
Crossref
Eva Leufven & Øystein Bruserud. (2019) Immunosuppression and Immunotargeted Therapy in Acute Myeloid Leukemia - The Potential Use of Checkpoint Inhibitors in Combination with Other Treatments. Current Medicinal Chemistry 26:28, pages 5244-5261.
Crossref
Crossref
Constantin N. Baxevanis, Michael Sofopoulos, Sotirios P. Fortis & Sonia A. Perez. (2019) The role of immune infiltrates as prognostic biomarkers in patients with breast cancer. Cancer Immunology, Immunotherapy 68:10, pages 1671-1680.
Crossref
Crossref
Florina Iliescu, Danilo Vrtačnik, Pavel Neuzil & Ciprian Iliescu. (2019) Microfluidic Technology for Clinical Applications of Exosomes. Micromachines 10:6, pages 392.
Crossref
Crossref
Ilaria Porcellato, Chiara Brachelente, Livia De Paolis, Laura Menchetti, Serenella Silvestri, Monica Sforna, Gaia Vichi, Selina Iussich & Luca Mechelli. (2018) FoxP3 and IDO in Canine Melanocytic Tumors. Veterinary Pathology 56:2, pages 189-199.
Crossref
Crossref
Xue Wang, Feng-Feng Ping, Sahar Bakht, Jingjing Ling & Waseem Hassan. (2019) Immunometabolism features of metabolic deregulation and cancer. Journal of Cellular and Molecular Medicine 23:2, pages 694-701.
Crossref
Crossref
Yi-Na Liu, Han Zhang, Lin Zhang, Ting-Ting Cai, Dai-Jia Huang, Jia He, Huan-He Ni, Fang-Jian Zhou, Xiao-Shi Zhang & Jiang Li. (2019) Sphingosine 1 phosphate receptor-1 (S1P1) promotes tumor-associated regulatory T cell expansion: leading to poor survival in bladder cancer. Cell Death & Disease 10:2.
Crossref
Crossref
David A. Bernal-Estévez, Oscar García, Ramiro Sánchez & Carlos A. Parra-López. (2018) Monitoring the responsiveness of T and antigen presenting cell compartments in breast cancer patients is useful to predict clinical tumor response to neoadjuvant chemotherapy. BMC Cancer 18:1.
Crossref
Crossref
Chunping Ao & Kang Zeng. (2018) The role of regulatory T cells in pathogenesis and therapy of human papillomavirus-related diseases, especially in cancer. Infection, Genetics and Evolution 65, pages 406-413.
Crossref
Crossref
Lien Lybaert, Karim Vermaelen, Bruno G. De Geest & Lutz Nuhn. (2018) Immunoengineering through cancer vaccines – A personalized and multi-step vaccine approach towards precise cancer immunity. Journal of Controlled Release 289, pages 125-145.
Crossref
Crossref
Robert D. Leone, Im-Meng Sun, Min-Hee Oh, Im-Hong Sun, Jiayu Wen, Judson Englert & Jonathan D. Powell. (2018) Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models. Cancer Immunology, Immunotherapy 67:8, pages 1271-1284.
Crossref
Crossref
Naoki Hosaka. (2018) Role of Regulatory T Cells in Tumor-Bearing Mice Treated with Allo-Hematopoietic Stem Cell Transplantation Plus Thymus Transplantation. Journal of Immunology Research 2018, pages 1-7.
Crossref
Crossref
M-N Theodoraki, T K Hoffmann & T L Whiteside. (2018) Separation of plasma-derived exosomes into CD3(+) and CD3(−) fractions allows for association of immune cell and tumour cell markers with disease activity in HNSCC patients. Clinical and Experimental Immunology 192:3, pages 271-283.
Crossref
Crossref
William R. Gwin & Mary L. Disis. 2018. Immunotherapy in Translational Cancer Research. Immunotherapy in Translational Cancer Research
228
251
.
Maysa Sarhan, Walter G. Land, Wulf Tonnus, Christian P. Hugo & Andreas Linkermann. (2018) Origin and Consequences of Necroinflammation. Physiological Reviews 98:2, pages 727-780.
Crossref
Crossref
Cristina Gutiérrez-Vázquez & Francisco J. Quintana. (2018) Regulation of the Immune Response by the Aryl Hydrocarbon Receptor. Immunity 48:1, pages 19-33.
Crossref
Crossref
Marek Nowak, Ewa Głowacka, Przemysław Lewkowicz, Małgorzata Banasik, Krzysztof Szyłło, Kinga Zimna, Katarzyna Bednarska & Magdalena Klink. (2018) Sub-optimal primary surgery leads to unfavorable immunological changes in ovarian cancer patients. Immunobiology 223:1, pages 1-7.
Crossref
Crossref
Elena Niccolai, Federica Ricci, Edda Russo, Giulia Nannini, Giacomo Emmi, Antonio Taddei, Maria Novella Ringressi, Filippo Melli, Manouela Miloeva, Fabio Cianchi, Paolo Bechi, Domenico Prisco & Amedeo Amedei. (2017) The Different Functional Distribution of “Not Effector” T Cells (Treg/Tnull) in Colorectal Cancer. Frontiers in Immunology 8.
Crossref
Crossref
M. Frydrychowicz, M. Boruczkowski, A. Kolecka-Bednarczyk & G. Dworacki. (2017) The Dual Role of Treg in Cancer. Scandinavian Journal of Immunology 86:6, pages 436-443.
Crossref
Crossref
Katrina E. Allison, Brenda L. Coomber & Byram W. Bridle. (2017) Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes. Immunology 152:2, pages 175-184.
Crossref
Crossref
Sara Santagata, Maria Napolitano, Crescenzo D'Alterio, Sonia Desicato, Salvatore Di Maro, Luciana Marinelli, Alessandra Fragale, Maria Buoncervello, Francesco Persico, Lucia Gabriele, Ettore Novellino, Nicola Longo, Sandro Pignata, Sisto Perdonà & Stefania Scala. (2017) Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer. Oncotarget 8:44, pages 77110-77120.
Crossref
Crossref
Ruth J. Davis, Ellen C. Moore, Paul E. Clavijo, Jay Friedman, Harrison Cash, Zhong Chen, Chris Silvin, Carter Van Waes & Clint Allen. (2017) Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ. Cancer Research 77:10, pages 2607-2619.
Crossref
Crossref
Jianda Yuan, Priti S. Hegde, Raphael Clynes, Periklis G. Foukas, Alexandre Harari, Thomas O. Kleen, Pia Kvistborg, Cristina Maccalli, Holden T. Maecker, David B. Page, Harlan Robins, Wenru Song, Edward C. Stack, Ena Wang, Theresa L. Whiteside, Yingdong Zhao, Heinz Zwierzina, Lisa H. Butterfield & Bernard A. Fox. (2016) Novel technologies and emerging biomarkers for personalized cancer immunotherapy. Journal for ImmunoTherapy of Cancer 4:1.
Crossref
Crossref
W.G. Land, P. Agostinis, S. Gasser, A.D. Garg & A. Linkermann. (2016) DAMP—Induced Allograft and Tumor Rejection: The Circle Is Closing. American Journal of Transplantation 16:12, pages 3322-3337.
Crossref
Crossref
Morteza Jafarinia, Fereshteh Mehdipour, Seyed Vahid Hosseini, Leila Ghahramani, Masood Hosseinzadeh & Abbas Ghaderi. (2016) Determination of a CD4+CD25−FoxP3+ T cells subset in tumor-draining lymph nodes of colorectal cancer secreting IL-2 and IFN-γ. Tumor Biology 37:11, pages 14659-14666.
Crossref
Crossref
Maria Isabel Carvalho, Isabel Pires, Justina Prada, Hugo Gregório, Luis Lobo & Felisbina L. Queiroga. (2016) Intratumoral FoxP3 expression is associated with angiogenesis and prognosis in malignant canine mammary tumors. Veterinary Immunology and Immunopathology 178, pages 1-9.
Crossref
Crossref
Belal Chaudhary & Eyad Elkord. (2016) Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting. Vaccines 4:3, pages 28.
Crossref
Crossref
Eyad Elkord. (2016) Helios Should Not Be Cited as a Marker of Human Thymus-Derived Tregs. Commentary: Helios+ and Helios− Cells Coexist within the Natural FOXP3+ T Regulatory Cell Subset in Humans. Frontiers in Immunology 7.
Crossref
Crossref
Pamela L. Beatty, Rick van der Geest, Jana G. Hashash, Takashi Kimura, Dmitriy Gutkin, Randall E. Brand & Olivera J. Finn. (2016) Immunobiology and immunosurveillance in patients with intraductal papillary mucinous neoplasms (IPMNs), premalignant precursors of pancreatic adenocarcinomas. Cancer Immunology, Immunotherapy 65:7, pages 771-778.
Crossref
Crossref
Theresa L. Whiteside. 2016. Manual of Molecular and Clinical Laboratory Immunology. Manual of Molecular and Clinical Laboratory Immunology
296
299
.
Barbara Metzler, Patrick Gfeller & Elisabeth Guinet. (2016) Restricting Glutamine or Glutamine-Dependent Purine and Pyrimidine Syntheses Promotes Human T Cells with High FOXP3 Expression and Regulatory Properties. The Journal of Immunology 196:9, pages 3618-3630.
Crossref
Crossref
Theresa L. Whiteside, Sandra Demaria, Maria E. Rodriguez-Ruiz, Hassane M. Zarour & Ignacio Melero. (2016) Emerging Opportunities and Challenges in Cancer Immunotherapy. Clinical Cancer Research 22:8, pages 1845-1855.
Crossref
Crossref
Sumita Trivedi, Clark A. Rosen & Robert L. Ferris. (2016) Current understanding of the tumor microenvironment of laryngeal dysplasia and progression to invasive cancer. Current Opinion in Otolaryngology & Head and Neck Surgery 24:2, pages 121-127.
Crossref
Crossref
Seyed-Mostafa Razavi, Karen E. Lee, Benjamin E. Jin, Parvir S. Aujla, Sharareh Gholamin & Gordon Li. (2016) Immune Evasion Strategies of Glioblastoma. Frontiers in Surgery 3.
Crossref
Crossref
MINGYUE LI, SHUGANG XING, HAIYING ZHANG, SIQI SHANG, XIANGXIANG LI, BO REN, GAIYUN LI, XIAONA CHANG, YILEI LI & WEI LI. (2016) A matrix metalloproteinase inhibitor enhances anti-cytotoxic T lymphocyte antigen-4 antibody immunotherapy in breast cancer by reprogramming the tumor microenvironment. Oncology Reports 35:3, pages 1329-1339.
Crossref
Crossref
Laurent Muller, Masato Mitsuhashi, Patricia Simms, William E. Gooding & Theresa L. Whiteside. (2016) Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets. Scientific Reports 6:1.
Crossref
Crossref
A. Ulges, E. Schmitt, C. Becker & T. Bopp. 2016.
1
46
.
Shigetaka Shimodaira, Kenji Sano, Koichi Hirabayashi, Terutsugu Koya, Yumiko Higuchi, Yumiko Mizuno, Naoko Yamaoka, Miki Yuzawa, Takashi Kobayashi, Kenichi Ito & Tomonobu Koizumi. (2015) Dendritic Cell-Based Adjuvant Vaccination Targeting Wilms’ Tumor 1 in Patients with Advanced Colorectal Cancer. Vaccines 3:4, pages 1004-1018.
Crossref
Crossref
Theresa L. Whiteside. (2014) Clinical Impact of Regulatory T cells (Treg) in Cancer and HIV. Cancer Microenvironment 8:3, pages 201-207.
Crossref
Crossref
Jerry L. Adams, James Smothers, Roopa Srinivasan & Axel Hoos. (2015) Big opportunities for small molecules in immuno-oncology. Nature Reviews Drug Discovery 14:9, pages 603-622.
Crossref
Crossref
Eyad Elkord, May Abd Al Samid & Belal Chaudhary. (2015) Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP. Oncotarget 6:24, pages 20026-20036.
Crossref
Crossref